These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18832904)

  • 1. Comparative effects of atrial polypeptide and neurohormone C on the interaction of factor Xa with antithrombin III.
    Coggin MH; Srapionian RM; Brecher AS; Galoyan AA
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):645-51. PubMed ID: 18832904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protamine sulfate stimulates degradation of factor Xa and the factor Xa-antithrombin complex.
    Coggin MH; Ahl R; Roland A; Beck D; Brecher AS
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):247-53. PubMed ID: 21297450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of blood coagulation factor Xaalpha autoproteolytic conversion to factor Xabeta. Effect on inhibition by antithrombin, prothrombinase assembly, and enzyme activity.
    Pryzdial EL; Kessler GE
    J Biol Chem; 1996 Jul; 271(28):16621-6. PubMed ID: 8663222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoproteolysis or plasmin-mediated cleavage of factor Xaalpha exposes a plasminogen binding site and inhibits coagulation.
    Pryzdial EL; Kessler GE
    J Biol Chem; 1996 Jul; 271(28):16614-20. PubMed ID: 8663221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte uptake of alpha 1-proteinase inhibitor-trypsin complexes in vitro: evidence for a shared uptake mechanism for proteinase complexes of alpha 1-proteinase inhibitor and antithrombin III.
    Fuchs HE; Michalopoulos GK; Pizzo SV
    J Cell Biochem; 1984; 25(4):231-43. PubMed ID: 6334690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of factor Xa-antithrombin III in plasma: relationship to prothrombin activation in vivo.
    Gouin-Thibault I; Dewar L; Kulczycky M; Sternbach M; Ofosu FA
    Br J Haematol; 1995 Jul; 90(3):669-80. PubMed ID: 7647008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effect of Platelet Factor 4 on the activities of Factor Xa.
    Fiore MM; Mackie IJ
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1072-5. PubMed ID: 19150337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of intravenous injection of sulphated galactomannan on anticoagulant activity of rat plasma].
    Drozd NN; Makarov VA; Tolstenkov AS; Lapikova ES; Miftakhova NT; Mestechkina NM; Shcherbukhin VD; Il'ina AV; Varlamov VP
    Patol Fiziol Eksp Ter; 2008; (3):20-3. PubMed ID: 18946908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of antithrombin III, activated protein C and heparin on the inhibition of the tissue thromboplastin-mediated coagulation.
    Hirahara K; Etoh Y; Matsuishi T; Suzuki N; Kurata M
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):692-6. PubMed ID: 2752479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protamine inhibits formation of the covalent factor IXa-anti-thrombin complex.
    Brecher AS; Roland AR
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):591-6. PubMed ID: 18685444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of calcium ions on the interactions between antithrombin and factor Xa mediated by variously sulfated, semisynthetic low-molecular-weight heparins.
    Sissi C; Lucatello L; Naggi A; Torri G; Palumbo M
    Semin Thromb Hemost; 2002 Aug; 28(4):355-60. PubMed ID: 12244482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of antithrombin III from human plasma by two-dimensional gel electrophoresis and capillary electrophoretic methods.
    Kremser L; Brückner A; Heger A; Grunert T; Buchacher A; Josic D; Allmaier G; Rizzi A
    Electrophoresis; 2003 Dec; 24(24):4282-90. PubMed ID: 14679575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of an antithrombotic agent antithrombin III - factor Xa complex.
    Bajwa SS
    Proc West Pharmacol Soc; 1982; 25():1-5. PubMed ID: 7122480
    [No Abstract]   [Full Text] [Related]  

  • 14. Design, synthesis, and biological activity of novel factor Xa inhibitors: improving metabolic stability by S1 and S4 ligand modification.
    Komoriya S; Kobayashi S; Osanai K; Yoshino T; Nagata T; Haginoya N; Nakamoto Y; Mochizuki A; Nagahara T; Suzuki M; Shimada T; Watanabe K; Isobe Y; Furugoori T
    Bioorg Med Chem; 2006 Mar; 14(5):1309-30. PubMed ID: 16263291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor Xa: at the crossroads between coagulation and signaling in physiology and disease.
    Borensztajn K; Peppelenbosch MP; Spek CA
    Trends Mol Med; 2008 Oct; 14(10):429-40. PubMed ID: 18774340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and anticoagulation activity of sodium cellulose sulfate.
    Wang ZM; Li L; Zheng BS; Normakhamatov N; Guo SY
    Int J Biol Macromol; 2007 Oct; 41(4):376-82. PubMed ID: 17602735
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Lu Z; Wang F; Liang M
    Clin Sci (Lond); 2017 May; 131(9):823-831. PubMed ID: 28424376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hyperglycemic byproduct methylglyoxal impairs anticoagulant activity through covalent adduction of antithrombin III.
    Jacobson R; Mignemi N; Rose K; O'Rear L; Sarilla S; Hamm HE; Barnett JV; Verhamme IM; Schoenecker J
    Thromb Res; 2014 Dec; 134(6):1350-7. PubMed ID: 25307422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring direct FXa-inhibitors and fondaparinux by Prothrombinase-induced Clotting Time (PiCT): relation to FXa-activity and influence of assay modifications.
    Harder S; Parisius J; Picard-Willems B
    Thromb Res; 2008; 123(2):396-403. PubMed ID: 18571698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of acylguanidine FXa inhibitors.
    O'Connor SP; Atwal K; Li C; Liu EC; Seiler SM; Shi M; Shi Y; Stein PD; Wang Y
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4696-9. PubMed ID: 18644722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.